bosentan anhydrous has been researched along with Experimental Mammary Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allen, LD; Castillo, CI; Dréau, D; Eddy, JM; Jewell, AN; McDermott, KA; Swamydas, M; Wyan, H | 1 |
1 other study(ies) available for bosentan anhydrous and Experimental Mammary Neoplasms
Article | Year |
---|---|
The endothelin axis stimulates the expression of pro-inflammatory cytokines and pro-migratory molecules in breast cancer.
Topics: Animals; Antihypertensive Agents; Bone Neoplasms; Bosentan; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cytokines; Endothelin Receptor Antagonists; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Female; Inflammation Mediators; Interleukin-17; Interleukin-1alpha; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neutrophils; Receptors, Endothelin; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Tumor Burden; Tumor Necrosis Factor-alpha | 2010 |